Insulet (PODD)

• Market cap: $20.2B
• 1 day: -0.44%
• 5 days: -0.85%
• 1 month: -7.55%
• 3 months: -7.49%
• 6 months: -8.54%
• Year to date: 11.88%
• 1 year: 9.11%
• 5 years: 10.25%
• 10 years: 630.82%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 3,900